I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Activity of dalotuzumab, a selective anti-IGF1R antibody, i..:
Moran, Teresa
;
Felip, Enriqueta
;
Keedy, Vicki
...
http://www.ehoonline.org/content/3/1/26. , 2014
Link:
http://www.ehoonline.org/content/3/1/26
RT Journal T1
Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial
UL https://suche.suub.uni-bremen.de/peid=base-ftbiomed:oai:biomedcentral.com:2162-3619-3-26&Exemplar=1&LAN=DE A1 Moran, Teresa A1 Felip, Enriqueta A1 Keedy, Vicki A1 Borghaei, Hossein A1 Shepherd, Frances A A1 Insa, Amelia A1 Brown, Holly A1 Fitzgerald, Timothy A1 Sathyanarayanan, Sriram A1 Reilly, John F A1 Mauro, David A1 Hsu, Karl A1 Yan, Li A1 Johnson, David H PB BioMed Central Ltd. YR 2014 K1 Non-small-cell lung cancer K1 Epidermal growth factor receptor K1 Insulin growth factor receptor K1 Dalotuzumab K1 Phase I/II trial JF http://www.ehoonline.org/content/3/1/26 LK http://www.ehoonline.org/content/3/1/26 DO http://www.ehoonline.org/content/3/1/26 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)